Clinica De Oncologia Medica Y Hematologica Del Este is categorized under Doctors in , and active since 2001.
Clinica De Oncologia Medica Y Hematologica Del Este was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ivan E Aponte at the company’s single location by writing to 263 Calle Font Martelo, , 00791 or by phoning (787) 850-6009. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinica De Oncologia Medica Y Hematologica Del Este |
| Contact Person: | Ivan E Aponte |
| Address: | 263 Calle Font Martelo, , 00791 |
| Phone Number: | (787) 850-6009 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Clinica De Oncologia Medica Y Hematologica Del Este was started in 2001 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ivan E Aponte for inquiries that concern Clinica De Oncologia Medica Y Hematologica Del Este by calling the company number (787) 850-6009, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinica De Oncologia Medica Y Hematologica Del Este can be found at the coordinates as well as the street address 263 Calle Font Martelo in , 00791.
For its online presence, you may visit Clinica De Oncologia Medica Y Hematologica Del Este’s website at and engage with its social media outlets through on Twitter and on Facebook.